Forma Therapeutics Holdings, Inc. Common Stock

FMTX

Capitalización de mercado USD 958 M

Acerca de: Forma Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. The firm's pipeline products are Etavopivat, FT-7051, FT-8225, and others.

Empleados: 189